Failure of "optimal" four-drug short-course tuberculosis chemotherapy in a compliant patient with human immunodeficiency virus.
D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006679:HIV Seropositivity / Q000150:complications* / Q000276:immunology; D006801:Humans; D008297:Male; D009894:Opportunistic Infections / Q000188:drug therapy* / Q000276:immunology; D010349:Patient Compliance; D011020:Pneumonia, Pneumocystis / Q000473:pathology; D012008:Recurrence; D012611:Scrotum; D013733:Testicular Diseases / Q000188:drug therapy / Q000276:immunology; D013997:Time Factors; D014389:Tuberculosis, Male Genital / Q000188:drug therapy / Q000276:immunology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000276:immunology
D000995:Antitubercular Agents